Preprint Case Report Version 1 Preserved in Portico This version is not peer-reviewed

Liver-Kidney-Heart Axis – A Clinical Challenge

Version 1 : Received: 18 January 2024 / Approved: 19 January 2024 / Online: 19 January 2024 (13:11:37 CET)

How to cite: Neto, D.F.; Blanco, I.; Viu, M.M.; Perez, D.D.; Romo, A.I. Liver-Kidney-Heart Axis – A Clinical Challenge. Preprints 2024, 2024011490. https://doi.org/10.20944/preprints202401.1490.v1 Neto, D.F.; Blanco, I.; Viu, M.M.; Perez, D.D.; Romo, A.I. Liver-Kidney-Heart Axis – A Clinical Challenge. Preprints 2024, 2024011490. https://doi.org/10.20944/preprints202401.1490.v1

Abstract

Cirrhosis is a chronic disease with multiple etiologies, multiple manifestations, and multi-organ involvement. Affects about 200 million people worldwide. Its main complication is Portal hypertension (PHT). Cirrhotic cardiomyopathy is a consequence of PHT, with heart failure (HF) being the main manifestation. On the other hand, for people with cardiopathy due to other reasons beyond cirrhosis, the presence of the last could act as a trigger to acute HF. Finally, when HF and cirrhosis coexist, the renal system suffers the most, originating from type-5 cardio-renal syndrome, a complex entity with many challenges in diagnosis and treatment. This entity was recently defined and there is a lack of data on the epidemiology of this syndrome. A 77-year-old woman, with cardiovascular risk factors; heart failure with reduced ejection fraction (HFrEF), secondary ischemic and valvular cardiopathy, chronic Kidney disease (CKD), and stable decompensated cirrhosis, went to the emergency department after progressive abdominal perimeter augmentation, legs’ edema and hematochezia. It was assumed acute decompensated cirrhosis and acute decompensated chronic kidney disease, had triggered digestive bleeding and the patient stayed hospitalized. Intravenous diuretic therapy was started but, the ascites and kidney function got worse, the Nt pro-BNP grew until 1125000 pg/ml, and a transthoracic echocardiography showed important signs of congestion, isolated right ventricular dysfunction, with normal cardiac output. After teamwork’s discussion, a type-5 cardio-renal syndrome was assumed deciding not to act on tricuspid regurgitation due to the maladaptive RV remodeling. Hepatorenal syndrome treatment was begun (oral terlipressin and intravenous albumin), followed by decongestion therapy, resulting in a marked improvement in clinical presentation. The kidney, heart, and liver recovered to these basal states. With this clinical case, the authors want to show how multidisciplinary management is important to face tricuspid regurgitation and right ventricular dysfunction.

Keywords

type-5 cardio-renal syndrome; heart failure; cirrhosis; Liver-Kidney-Heart axis

Subject

Medicine and Pharmacology, Internal Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.